Arginine Metabolism in Youth With Type 2 Diabetes

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 20
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
30 (estimated)
Sponsor
Baylor College of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Type 2 diabetes (T2D), once considered only "a disease of older ages," is now a significant public health concern in youth. Although it is characterized by insulin resistance and impaired insulin secretion, its precise etiology and pathogenesis are not yet fully understood. This study aims to (1) explore arginine metabolism in youth with T2D via safe, minimally invasive kinetic experiments using s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Youth with type 2 diabetes and healthy controls who meet other inclusion criteria outlined below. 2. Age and pubertal stage criteria (12- to 20-year-old girls who are postmenarchal, and 14- to 20-year-old boys who are at Tanner stage 5 genitalia), 3. Additional criteria for y…
Contacts

Mustafa Tosur, MD

832-822-3780

mustafa.tosur@bcm.edu

CONTACT

Lori Malone

832-822-3784

lmalone@bcm.edu

CONTACT